49.0055
-0.4345 (-0.88%)
-0.4345 (-0.88%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| CRISPR Therapeutics AG | CRSP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.4345 | -0.88% | 49.0055 | 47.00 | 49.9974 | 47.52 | 49.44 | 11:07:14 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 48.97 | 49.09 | 0.12 | 0.24% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,901 | 479,547 | $ 48.61 | $ 23,308,419 | 1,092,906 | 33.55 - 74.48 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:06:38 | 200 | $ 49.0055 | USD |
CRISPR Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 2.98B | 60.85M | $ -164.98M | 0.98 | 57.90 | 59.98M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
CRISPR Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRSP Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 56.69 | 57.0682 | 47.00 | 51.04 | 1,121,956 | -7.68 | -13.56% |
| 1 Month | 52.44 | 61.90 | 47.00 | 54.63 | 1,125,202 | -3.43 | -6.55% |
| 3 Months | 71.48 | 73.6077 | 47.00 | 59.30 | 1,051,872 | -22.47 | -31.44% |
| 6 Months | 44.50 | 74.48 | 35.46 | 57.29 | 929,554 | 4.51 | 10.12% |
| 1 Year | 36.85 | 74.48 | 33.55 | 51.64 | 754,081 | 12.16 | 32.99% |
| 3 Years | 20.16 | 74.48 | 13.50 | 46.68 | 725,592 | 28.85 | 143.08% |
| 5 Years | 15.00 | 74.48 | 11.63 | 46.16 | 660,810 | 34.01 | 226.7% |
CRISPR Therapeutics Description
| CRISPR Therapeutics AG is a gene-editing company. It is engaged in the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 is a technology that allows for precise, directed changes to genomic DNA. The company advanced programs target beta-thalassemia and sickle cell disease, two hemoglobinopathies that have a high unmet medical need. |
